Immunotherapy in Head and Neck Squamous Cell Cancer

Immunotherapy in Head and Neck Squamous Cell Cancer

Prognosis in relapsed metastatic head and neck squamous cell cancer (RM-HNSCC) is dismal. Platinum based chemotherapy in combination with Cetuximab is used in first-line setting, while no further validated options are available at progression. Immunotherapy has produced durable clinical benefit in s...

Full description

Bibliographic Details
Main Authors: Nerina Denaro, Marco Carlo Merlano
Format: Article
Language:English
Published: Korean Society of Otorhinolaryngology-Head and Neck Surgery 2018-12-01
Series:Clinical and Experimental Otorhinolaryngology
Subjects:
Immunotherapy
Tumor Immune Escape
Squamous Cell Carcinoma
Head And Neck
Biomarkers
Online Access:http://www.e-ceo.org/upload/pdf/ceo-2018-00150.pdf

Similar Items

Similar Items